Founder, President Emeritus and Senior Investigator, Gladstone Institutes, San Francisco, California
Internationally known expert on heart disease, cholesterol metabolism and Alzheimer’s
Carrolee Barlow, MD, PhD
Chief Medical Officer, E-Scape, San Francisco, California
Renowned expert in neurodegeneration and clinical development of new therapies
Terence Burns, MD, PhD
Neuro Surgeon, Mayo Clinic, Rochester, Minnesota
Focused on brain tumors and translation of neuroregenerative therapies
Santosh Kesari, MD, PhD
Chair and Professor, Department of Translational Neurosciences and Neurotherapeutics, St John’s Health Center; Director, Neuro-oncology, Pacific Neuroscience Institute, Santa Monica, California
Bernhard Landwehrmeyer, MD, PhD
Professor of Neurology, Universität Ulm, Ulm, Germany
Renowned expert on Huntington’s disease (HD), and Global PI at Enroll-HD study
Wolfgang H. Oertel, MD, PhD
Director, Department of Neurology, Philipps-Universität, Marburg, Germany
Expert on Alzheimer’s, Parkinson’s and related dementias
Martin Schalling, MD, PhD
Professor of Medical Genetics at the Center for Molecular Genetics, Karolinska Institute, Stockholm, Sweden
Expert on Bipolar and other Psychiatric disorders
Håkan Widner, MD, PhD
Professor of Neurology, Lund University, Lund, Sweden
Expert on Parkinson’s disease and other Movement disorders
Headquarters
NeuraMetrix, Inc. 65 Merrimon Ave #1181 Asheville, NC 28801-2322 U.S.A.
NeuraMetrix is a Medical Device company. It offers a novel, unique, highly accurate digital biomarker to detect and monitor a range of Neurological diseases and Psychiatric disorders.
Copyright NeuraMetrix, Inc. (a North Carolina corporation) 2023. CE marked according to MDD Class I devices, directive 93/42/EEC. Not FDA cleared. Website produced by Pinevision